Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management

MLA

Thomas A. Verbeek, MbChB, Mmed, et al. “Hypercoagulability in End-Stage Liver Disease: Review of Epidemiology, Etiology, and Management.” Transplantation Direct, vol. 4, no. 11, Nov. 2018, p. e403. EBSCOhost, https://doi.org/10.1097/TXD.0000000000000843.

APA

Thomas A. Verbeek, Mbc. Mm., Jonathan G. Stine, M. Ms., Fuat H. Saner, M. D., & Dmitri Bezinover, M., PhD. (2018). Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplantation Direct, 4(11), e403. https://doi.org/10.1097/TXD.0000000000000843

Chicago

Thomas A. Verbeek, MbChB, Mmed, MD, Msc Jonathan G. Stine, Md, Deaa Fuat H. Saner, and Md Dmitri Bezinover PhD. 2018. “Hypercoagulability in End-Stage Liver Disease: Review of Epidemiology, Etiology, and Management.” Transplantation Direct 4 (11): e403. doi:10.1097/TXD.0000000000000843.